Investor · 2 deals
St Lucia, QLD
Every published round University of Queensland took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Pollinate | Accelerator | Jan 2026 | $747k | Lead | FaBA, Business News Australia | |
| Pure Battery Technologies | Unnamed stage | 19 Nov 2018 | $1.7m | Participant | SmartCompany (Wed 1 May 2019), SmartCompany (Mon 19 Nov 2018) |
Companies University of Queensland has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Pollinate | Jan 2026, Accelerator | 1 | 1 | |
| Pure Battery Technologies | 19 Nov 2018 | 1 | 0 |
This is a stake in the fund itself, money that the fund's manager invests, not a stake in the fund manager.
| Fund | Manager | Sources |
|---|---|---|
| Uniseed | Uniseed | GBS Ventures, clinicalleader.com |
Companies University of Queensland has backed that another company then bought. An exit for the holding, not a deal University of Queensland did.
Stories naming University of Queensland. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
UQ spinout Proboxis Biotechnology has received $1.5 million via the first round of the Biointelect Venturer incubator to advance a vaccine platform against mosquito-borne diseases toward human clinical development.
Australian medtech Ceretas hit a milestone in its CUREator+ program, unlocking the final instalment of a government-funded grant; the piece also recaps its A$8 million IPO and ASX listing earlier in 2026.
University of Queensland researchers, funded by an Australian grant and working with cultivated-meat firm Magic Valley, found microalgae grown on production waste can recycle nutrients and sharply cut the cost of growing meat cells.
Weekly roundup: Constantinople raises $62.5m; Blackbird wraps fund six above $1b; Guardhouse buys Mobohubb; SCX.ai debuts on the ASX; plus seed rounds, exits and executive changes across the ecosystem.
Uniseed-backed Australian medtech Q-Sera's blood-clotting tube technology has debuted in Japan via Terumo's VenoJect II launch; the post also credits MRCF and UniQuest Extension Fund as backers.
Spirits giant Diageo has bought the Sydney-founded coffee liqueur maker Mr Black; the piece examines the price, the cocktail trend behind it, rival acquisitions, and what comes next for the brand.
A launch profile of Wingman Money, a personal finance app built by two University of Queensland graduates that rates financial wellbeing with a single score; its founders earlier took part in Startmate's 2025 pre-accelerator.
UQ medtech spin-out Ceretas sold its IPO, raising about $8 million, and now targets a fast-tracked ASX debut; the article also recalls ResApp's 2022 acquisition by Pfizer.
Also kalkine.com.au·Dealroom
Ceretas, a university spin-off, has sold A$8 million of shares in a stockmarket float valuing the ultrasound medtech at A$18 million, with the proceeds going toward device trials.
Also kalkine.com.au·Dealroom
FaBA profiles Nourish Ingredients, a Canberra startup using precision fermentation for dairy-style fats, recounting a co-investment project with Queensland academics that readied its Creamilux ingredient for commercial dairy customers.
Canberra medtech Dentroid has banked $32 million at a $265 million valuation, with Septodont both investing and signing a worldwide licensing deal for its light-based device that eases dental pain without needles.
Also Dealroom
Profile of a Peter Mac spinout advancing solid-tumour cell therapies; recounts its Series A backers, later investment, grant support, and chief executive Sam Cobb's earlier career building and listing AdAlta.
FaBA profiles Pollinate, a Brisbane startup founded by Adeep Mitra and Corey Berther that uses AI to automate food supply chain workflows, tracing its path from a university food challenge to Y Combinator backing.
Q-Sera's rapid-clotting blood tube technology has gone to market in Japan via Terumo's VenoJect II launch; the Melbourne startup's backers include MRCF, Uniseed and the UniQuest Extension Fund.
IP Group-backed copper-tech spin-out Banksia Minerals has won a federal renewable energy grant worth as much as $5 million, a year after banking $1.05 million in seed capital.
Eight university- and company-led Australian quantum projects share $12.7 million in stage-two Critical Technologies Challenge Program grants, funding prototypes for data-centre cooling, medical imaging and rare-earth detection.
Main Sequence announces backing Cortisonic, a deep-tech startup coming out of stealth with phononic chips for low-power edge AI, plus an Australian defence contract and a Lockheed Martin partnership.
Also Forbes Australia
A green-methanol developer announces a 1.4 million dollar federal CRC-P grant toward a 2.8 million dollar pilot plant with university and utility partners, plus a new lead chemist joining.
Artesian's write-up of its first Yield summit in Melbourne, where agrifood leaders discussed AI, biologicals, robotics, agri-energy and biosecurity, and how RDCs, investors and corporates can together speed Australian agricultural innovation.
A Queensland cattle genetics business has opened a laboratory to process bull semen at Glen Aplin with government grant support, and a partner will sort sexed semen there from early 2026.
Uniseed chief executive Peter Devine departs after two decades; Monash's Alistair Hick takes over in 2026. The piece recounts Uniseed's fund history and recent stakes in ENA Respiratory and Morse Micro rounds.
Roundup of Australian manufacturing items: gold-nanoparticle cancer diagnostics research, a medical research endowment's ten-year mark, a footballer's ambassador role, EU research program accession talks, a pectin producer's government grant, and battle-tank trainers.
Weekly roundup detailing five Australian raises: Vaxxas' Series D plus debt facility amid executive changes, Skutopia's growth round, Send Payments' backing and CEO change, Apate.ai's seed, and Coursebox's seed.
Also Startup Daily·SmartCompany·Australian FinTech·Dealroom·Startup Daily
Australian biotech Vaxxas secured a Series D plus a debt facility while overhauling leadership: a new chair, founding CEO shifting to an advisory role, and CFO made redundant amid job cuts.
Also Business News Australia·SmartCompany·Cut Through Venture·Startup Daily·Startup Daily·SmartCompany·Startup Daily
Queensland drug developer Lucia Bio added $2 million to its seed round from UniQuest Extension Fund and Uniseed-managed funds, bringing its overall raise to $3 million ahead of a planned Series A.
Vaxxas announced a roughly A$90m financing — Series D equity led by SPRIM Global Investments plus debt — to advance its needle-free vaccine patch, alongside leadership changes including a new chair.
Brandon BioCatalyst has named Peter Beattie its chair as Bill Ferris retires, with Andrew Nash joining the board and Ross King becoming deputy; manager Brandon Capital's newly raised $439 million fund was noted.
Sanofi is buying Vicebio for up to US$1.6 billion in the biggest-ever exit of Australian university IP, with UQ keeping equity; the article also recalls the Inflazome and Spinifex sales and Vicebio's Medicxi seed.
Weekly roundup of readers' five favourite stories: a hydrogen grant for 1414 Degrees, LS Precast's rail tunnel contract, AML3D's US Navy pact, quantum clock breakthrough, and Suntory Oceania's launch.
Proto Axiom has put $4 million into Sydney IVF biotech JumpStart Fertility, a UNSW spin-out, to pay for human trials of a treatment aimed at age-related fertility decline.
FaBA's accelerator program has handed a University of Queensland precision-fermentation dairy process to Sydney startup All G, which will scale it toward a milk supplement, with federal government support.
UniSuper adds a further $25 million to its backing of Uniseed, reaching $100 million in total support for the university research commercialisation fund; past cheques to quantum and biotech startups are recapped.
FaBA and UQ launch their largest research project, a $5.6m effort with oat company My PlantCo to develop new oat-based foods, with GRDC committing over $720,000 to the company's project.
Roundup of the publication's five most-read stories of the week: a $65 million grant for the SMART regenerative-therapies CRC, QUT's flexible semiconductor research, a Lima Declaration fact-check, and Greensteel Australia's $1.6 billion mill order.
Meat scientist Louwrens Hoffman joins FaBA and discusses meat quality, alternative proteins, sustainability and food waste in an interview.
Roundup of brief items: Memphasys hails fertility device trial results; a concrete recycler is fined; Wurrba, Hazer and University of Queensland land government grants; Aus J gains a North American distribution partner.
UniQuest and Molecule to Medicine have formed Curlew Bio to develop anti-inflammatory drugs, backed by $1 million from UniQuest's Extension Fund; the article also recalls Novartis's 2015 purchase of Spinifex Pharmaceuticals.
Profile of veterinarian-turned-businessman Glen Richards, covering his founding of Greencross, its ASX listing, his Shark Tank Australia role, other directorships, and his estimated wealth.
Weekly roundup of seven Australian and New Zealand raises totalling $42.8 million, spanning property-investment AI, workforce credentialing, allied-health practice software, conversation analytics, maths learning games, copper processing and holiday-park bookings.